ALLO icon

Allogene Therapeutics
ALLO

Overview Fund Activity

168 hedge funds and large institutions have $3.12B invested in Allogene Therapeutics in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 62 reducing their positions, and 29 closing their positions.

Holders
168
Holders Change
+4
Holders Change %
+2.44%
% of All Funds
2.96%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
44
Reduced
62
Closed
29
Calls
$16.5M
Puts
$4.53M
Net Calls
+$12M
Net Calls Change
+$12M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$20.8M
2
LOAMS
2
Lombard Odier Asset Management (Switzerland)
Switzerland
$18.9M
3
CLOS
3
Compagnie Lombard Odier SCmA
Switzerland
$18.9M
4
HM
4
HealthCor Management
New York
$17.5M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$84.1M

Top Sellers

1
State Street
1
State Street
Massachusetts
$82.4M
2
Capital International Investors
2
Capital International Investors
California
$233M
3
SCM
3
Suvretta Capital Management
New York
$0
4
CII
4
Capital International Inc
California
$0
5
Bank of America
5
Bank of America
North Carolina
$2.08M
Name Market Value Shares Shares
Change 		Shares
Change %
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$661M 18,716,306 – –
Capital Research Global Investors
2
Capital Research Global Investors
California
$447M 12,664,013 +23,675 +0.2%
Capital International Investors
3
Capital International Investors
California
$233M 6,599,036 -529,183 -7%
BlackRock
4
BlackRock
New York
$221M 6,270,078 -202,682 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$210M 5,956,693 +170,216 +3%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$122M 3,456,753 -103,040 -3%
AllianceBernstein
7
AllianceBernstein
Tennessee
$89.7M 2,541,559 -47,299 -2%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$84.1M 2,381,867 +424,778 +22%
State Street
9
State Street
Massachusetts
$82.4M 2,333,796 -1,039,665 -31%
Capital World Investors
10
Capital World Investors
California
$79.3M 2,246,603 -125,214 -5%
VVA
11
Vida Ventures Advisors
Massachusetts
$63.5M 1,798,163 – –
WCM
12
Wildcat Capital Management
New York
$53.5M 1,515,524 – –
Primecap Management
13
Primecap Management
California
$46.1M 1,305,400 +67,000 +5%
CC
14
Casdin Capital
New York
$45.9M 1,300,000 +355,000 +38%
Goldman Sachs
15
Goldman Sachs
New York
$45.2M 1,281,078 -108,588 -8%
PA
16
Perceptive Advisors
New York
$40.4M 1,143,790 – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$37.9M 1,072,831 +83,925 +8%
Norges Bank
18
Norges Bank
Norway
$33.9M 960,171 -176,037 -15%
Victory Capital Management
19
Victory Capital Management
Texas
$33.5M 948,859 -67,193 -7%
HA
20
HHLR Advisors
Cayman Islands
$28.2M 800,000 – –
ROTUOC
21
Regents of the University of California
California
$23.9M 675,743 -224,400 -25%
WP
22
Woodline Partners
California
$23.7M 672,644 +105,105 +19%
Northern Trust
23
Northern Trust
Illinois
$22.9M 648,464 -20,143 -3%
PHS
24
PFM Health Sciences
California
$20.8M 590,378 +590,378 New
Fidelity Investments
25
Fidelity Investments
Massachusetts
$20M 565,491 +69 +0%
1
2 3 4 5